+ Follow PROFESSOR PETER SLEIGHT Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 210719
[Title] => New hope for high-risk heart patients
[Summary] => Experts are seeing new hope in improving survival of high-risk heart patients. Tens of thousands of deaths each year may be prevented with the use of the class of cholesterol-lowering drugs called statins.
Heart experts worldwide are calling for a major change in treatment guidelines recommending statins in high-risk patients even if their blood cholesterol levels are just slightly elevated or still within normal limits. It is predicted that the results of recent landmark trials are set to revolutionize the way cholesterol-lowering drugs are prescribed.
[DatePublished] => 2003-06-19 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
PROFESSOR PETER SLEIGHT
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 210719
[Title] => New hope for high-risk heart patients
[Summary] => Experts are seeing new hope in improving survival of high-risk heart patients. Tens of thousands of deaths each year may be prevented with the use of the class of cholesterol-lowering drugs called statins.
Heart experts worldwide are calling for a major change in treatment guidelines recommending statins in high-risk patients even if their blood cholesterol levels are just slightly elevated or still within normal limits. It is predicted that the results of recent landmark trials are set to revolutionize the way cholesterol-lowering drugs are prescribed.
[DatePublished] => 2003-06-19 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
